newsfilter
← Latest News
GlobeNewswire·

Allena Pharmaceuticals Announces Initial Data from Phase 1 Trial of ALLN-346

-- Single-Ascending Doses of ALLN-346 Oral Enzyme Well-Tolerated ---- Non-Absorption of ALLN-346 Demonstrated ---- Advancing to Phase 1b Multiple-Ascending Dose Study and Phase 2 Proof-of-Concept...